4
Clinical Trials associated with [11C]MeDAS / WithdrawnEarly Phase 1IIT Phase 1 Study Evaluating the Safety of [11C]MeDAS Myelin-Targeting PET Agent in Humans
This study evaluates the safety of [11C]MeDAS, a PET radiotracer.
[11C]MeDAS PET: an imaging tool for quantitative assessment of changes in myelin density over time in multiple sclerosis - Changes in myelin density
/ CompletedNot Applicable [11C]MeDAS PET: a non-invasive imaging tool for quantitative assessment of myelin loss in multiple sclerosis - Myelin PET in MS
100 Clinical Results associated with [11C]MeDAS
100 Translational Medicine associated with [11C]MeDAS
100 Patents (Medical) associated with [11C]MeDAS
100 Deals associated with [11C]MeDAS